The role of discharge checklist in guideline-directed medical therapy for heart failure patients
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Initiation of guideline-directed medical therapy (GDMT) during hospitalization is recommended for patients with heart failure (HF). However, GDMT is underutilized in real-world practice. This study evaluated the role of a discharge checklist on GDMT. Methods: This was a single-center, observational study. The study included all patients hospitalized for HF between 2021 and 2022. The clinical data were retrieved from the electronic medical records and discharge checklist published by the Korean Society of Heart Failure. The adequacy of GDMT prescriptions was evaluated in three ways: the total number of GDMT drug classes and two types of adequacy scores. The primary endpoint was the incidence of all-cause mortality or rehospitalization due to HF within 2 months of discharge. Results: Overall, the checklist was completed by 244 patients (checklist group) and was not completed in 171 patients (non-checklist group). The baseline characteristics were comparable between two groups. At discharge, a higher proportion of patients in the checklist group received GDMT than in the non-checklist group (67.6% vs. 50.9%, p = 0.001). The incidence of primary endpoint was lower in the checklist group compared to the non-checklist group (5.3% vs. 11.7%, p = 0.018). The use of the discharge checklist was associated with significantly lower risk of death and rehospitalization in the multivariable analysis (hazard ratio, 0.45; 95% confidence interval, 0.23–0.92; p = 0.028). Conclusions: Discharge checklist usage is a simple but effective strategy for GDMT initiation during hospitalization. The discharge checklist was associated with better outcome in patients with HF.
Abstract
Background/Aims: Initiation of guideline-directed medical therapy (GDMT) during hospitalization is recommended for patients with heart failure (HF). However, GDMT is underutilized in real-world practice. This study evaluated the role of a discharge checklist on GDMT. Methods: This was a single-center, observational study. The study included all patients hospitalized for HF between 2021 and 2022. The clinical data were retrieved from the electronic medical records and discharge checklist published by the Korean Society of Heart Failure. The adequacy of GDMT prescriptions was evaluated in three ways: the total number of GDMT drug classes and two types of adequacy scores. The primary endpoint was the incidence of all-cause mortality or rehospitalization due to HF within 2 months of discharge. Results: Overall, the checklist was completed by 244 patients (checklist group) and was not completed in 171 patients (non-checklist group). The baseline characteristics were comparable between two groups. At discharge, a higher proportion of patients in the checklist group received GDMT than in the non-checklist group (67.6% vs. 50.9%, p = 0.001). The incidence of primary endpoint was lower in the checklist group compared to the non-checklist group (5.3% vs. 11.7%, p = 0.018). The use of the discharge checklist was associated with significantly lower risk of death and rehospitalization in the multivariable analysis (hazard ratio, 0.45; 95% confidence interval, 0.23–0.92; p = 0.028). Conclusions: Discharge checklist usage is a simple but effective strategy for GDMT initiation during hospitalization. The discharge checklist was associated with better outcome in patients with HF.
참고문헌 (25)
- Lee HY, "Paradigm shifts of heart failure therapy : do we need another paradigm?", Int J Heart Fail, 2, pp.145~156 (2020)
- Groenewegen A, "Epidemiology of heart failure", Eur J Heart Fail, 22, pp.1342~1356 (2020)
- 최홍미, "Update on heart failure management and future directions", The Korean Journal of Internal Medicine, 34(1), pp.11~43 (2019), 대한내과학회[DOI]
- Tromp J, "Heart failure with preserved ejection fraction in Asia", Eur J Heart Fail, 21, pp.23~36 (2019)
- Park Jin Joo, "Heart Failure Statistics in Korea, 2020: A Report from the Korean Society of Heart Failure", International Journal of Heart Failure, 3(4), pp.224~ (2021), 대한심부전학회[DOI]
- Writing Committee, "2021update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment : answers to 10 pivotal issues about heart failure with reduced ejection fraction : a report of the American College of Cardiology Solution Set Oversight Committee", J Am Coll Cardiol, 77, pp.772~810 (2021)
- Hyun-Jin Kim, "The effect of beta-blockers in acute heart failure according to heart rate", The Korean Journal of Internal Medicine, 36(4), pp.898~905 (2021), 대한내과학회[DOI]
- Heidenreich PA, "2022 AHA", ACC, American Heart Association Joint Committee on clinical practice guidelines, pp.Circulation, 2022[DOI]
- Chan Soon Park, "J-curve relationship between corrected QT interval and mortality in acute heart failure patients", The Korean Journal of Internal Medicine, 35(6), pp.1371~1384 (2020), 대한내과학회[DOI]
- McDonagh TA, "2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure", Eur Heart J, 42, pp.3599~3726 (2021)
- Maggioni AP, "EURObservational research programme : regional differences and 1-year follow-up results of the Heart Failure Pilot Survey(ESC-HF Pilot)", Eur J Heart Fail, 15, pp.808~817 (2013)
- 이상언, "Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF)", Korean Circulation Journal, 47(3), pp.341~353 (2017), 대한심장학회
- Basoor A, "Decreased readmissions and improved quality of care with the use of an inexpensive checklist in heart failure", Congest Heart Fail, 19, pp.200~206 (2013)
- Allain F, "Usefulness of a personalized algorithm-based discharge checklist in patients hospitalized for acute heart failure", ESC Heart Fail, 7, pp.1217~1223 (2020)
- DeFilippis EM, "Putting the"Optimal"in optimal medical therapy", JACC Heart Fail, 9, pp.39~41 (2021)
- Fonarow GC, "Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004 : findings from Acute Decompensated Heart Failure National Registry(ADHERE)", Am Heart J, 153, pp.1021~1028 (2007)
- Atherton JJ, "Patient characteristics from a regional multicenter database of acute decompensated heart failure in Asia Pacific(ADHERE International-Asia Pacific)", J Card Fail, 18, pp.82~88 (2012)
- Seo WW, "Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction : a cohort study", BMJ Open, 10, pp.e030514~ (2020)
- Smaha LA, "The American Heart Association get with the guidelines program", Am Heart J, 148, pp.S46~S48 (2004)
- Bergethon KE, "Trends in 30-day readmission rates for patients hospitalized with heart failure : findings from the get with the guidelines-Heart Failure Registry", Circ Heart Fail, 9, pp.10~ (2016)
- Lee SE, "A multicentre cohort study of acute heart failure syndromes in Korea : rationale, design, and interim observations of the Korean Acute Heart Failure(KorAHF)registry", Eur J Heart Fail, 16, pp.700~708 (2014)
- Hwang B, "Effects of educational intervention on mortality and patient-reported outcomes in individuals with heart failure : a randomized controlled trial", Patient Educ Couns, 105, pp.2740~2746 (2022)
- Yoo BS, "Survey of guideline adherence for treatment of systolic heart failure in real world(SUGAR) : a multi-center, retrospective, observational study", PLoS One, 9, pp.e86596~ (2014)
- El Hadidi S, "A tool for assessment of heart failure prescribing quality : a systematic review and meta-analysis", Pharmacoepidemiol Drug Saf, 27, pp.685~694 (2018)
- Legallois D, "Improving quality of care in patients with decompensated acute heart failure using a discharge checklist", Arch Cardiovasc Dis, 112, pp.494~501 (2019)